Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [916]
News [2620]
Articles [112]
Editorials [3]
Conferences [85]
elearning [27]
Efficacy and immune correlates of the SRA737 plus LDG regimen in combination...
Dr Triparna Sen - MD Anderson Cancer Center, Houston, Texas
Efficacy and immune correlates of the SRA737 plus LDG regimen in combination with anti-PD-L1 in an SCLC model ( Dr Triparna Sen - MD Anderson Cancer Center, Houston, Texas )
15 Apr 2019
TATTON: Osimertinib plus savolitinib for patients with EGFR-mutant, MET...
Prof Lecia Sequist - Massachusetts General Hospital, Boston, USA
TATTON: Osimertinib plus savolitinib for patients with EGFR-mutant, MET-amplified NSCLC after progression on EGFR-TKI ( Prof Lecia Sequist - Massachusetts General Hospital, Boston, USA )
15 Apr 2019
Using regionally delivered autologous mesothelin-targeted CAR T cells in the...
Dr Prasad Adusumilli - Memorial Sloan Kettering Cancer Center, New York, USA
Using regionally delivered autologous mesothelin-targeted CAR T cells in the treatment of malignant pleural disease ( Dr Prasad Adusumilli - Memorial Sloan Kettering Cancer Center, New York, USA )
15 Apr 2019
KEYNOTE 189: Targeting NSCLC patients with brain and liver metastases
Dr Marina Garassino - National Tumor Institute, Milan, Italy
KEYNOTE 189: Targeting NSCLC patients with brain and liver metastases ( Dr Marina Garassino - National Tumor Institute, Milan, Italy )
15 Apr 2019
MYSTIC: Developing biomarkers for metastatic NSCLC
Prof Solange Peters - Centre Hospitalier Universitaire Vaudois, Lausanne...
MYSTIC: Developing biomarkers for metastatic NSCLC ( Prof Solange Peters - Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland )
11 Apr 2019
TATTON: Updated results for patients with EGFR-mutant NSCLC
Prof Leica Sequist - Massachusetts General Hospital, Boston, USA
TATTON: Updated results for patients with EGFR-mutant NSCLC ( Prof Leica Sequist - Massachusetts General Hospital, Boston, USA )
11 Apr 2019
KEYNOTE trials show pembrolizumab benefited patients with advanced small cell...
Prof Hyun Cheol Chung - Yonsei University, Seoul, South Korea
KEYNOTE trials show pembrolizumab benefited patients with advanced small cell lung cancer ( Prof Hyun Cheol Chung - Yonsei University, Seoul, South Korea )
11 Apr 2019
Perception of tobacco use in young adults of urban India
Ms Soumita Ghose - Tata Medical Centre, Kolkata, India
Perception of tobacco use in young adults of urban India ( Ms Soumita Ghose - Tata Medical Centre, Kolkata, India )
28 Mar 2019
Nivolumab in combination with CIMAvax-EGF for lung cancer
Dr Grace Dy - Roswell Park Cancer Institute, USA
Nivolumab in combination with CIMAvax-EGF for lung cancer ( Dr Grace Dy - Roswell Park Cancer Institute, USA )
4 Jan 2019
Large food and alcohol companies are undermining public health
Prof Rob Moodie, Melbourne School of Population and Global Health, Malawi...
Large food and alcohol companies are undermining public health ( Prof Rob Moodie, Melbourne School of Population and Global Health, Malawi College of Medicine )
6 Nov 2018
Alcohol consumption and cognitive dissonance in the west
Prof Terry Slevin, Public Health Association of Australia
Alcohol consumption and cognitive dissonance in the west ( Prof Terry Slevin, Public Health Association of Australia )
6 Nov 2018
Using genetics to close the knowledge gap on cancer causation
Dr Paul Brennan, International Agency for Research On Cancer (IARC) (France
Using genetics to close the knowledge gap on cancer causation ( Dr Paul Brennan, International Agency for Research On Cancer (IARC) (France )
6 Nov 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation